NYSE American
PLX
Protalix BioTherapeutics, Inc.
- Health Care
- Israel
- 1 day
- +0.0%
- 1 month
- +3.4%
- 1 year
- +64.9%
$2.44 · Mkt cap $197M
At the 6 Aug 2026 close
NYSE American
Protalix BioTherapeutics, Inc.
$2.44 · Mkt cap $197M
At the 6 Aug 2026 close
Protalix BioTherapeutics, Inc. trades under the ticker PLX on NYSE American, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). Its market capitalisation is $197M. The last closing price was $2.44, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +64.9%, and +3.4% over the past month. Returns are price returns and exclude dividends.
This page exists because PLX is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.